Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin

BMC Microbiology

Volumn 16, Issue 1, 2016, Pages

  Jo, Ara ^a   Ahn, Juhee ^a  

^a Kangwon National University   (South Korea)

Author keywords

Antibiotic resistance; Biofilm; Efflux pump; Gene expression; Lactamase; Levofloxacin; Oxacillin; Staphylococcus aureus

Indexed keywords

2 NAPHTHYLAMINE; AMPICILLIN; BETA LACTAMASE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NORFLOXACIN; OXACILLIN; PHENYLALANINE ARGININE BETA NAPHTHYLAMIDE; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; ADHESIN; BACTERIAL PROTEIN; CARRIER PROTEIN; CLFA PROTEIN, STAPHYLOCOCCUS AUREUS; CLFB PROTEIN, STAPHYLOCOCCUS AUREUS; COAGULASE; DIPEPTIDE; PHENYLALANINE ARGININE BETA-NAPHTHYLAMIDE; QACA PROTEIN, STAPHYLOCOCCUS AUREUS; QACB PROTEIN, STAPHYLOCOCCUS AUREUS;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BIOFILM; CLFA GENE; CLFB GENE; CONTROLLED STUDY; ENO GENE; FNBA GENE; FNNB GENE; GENE EXPRESSION; ICAD GENE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NORB GENE; NORC GENE; QACA GENE; QACB GENE; SEC GENE; STAPHYLOCOCCUS AUREUS; BACTERIUM ADHERENCE; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; PHENOTYPE; POLYMERASE CHAIN REACTION;

ADHESINS, BACTERIAL; BACTERIAL ADHESION; BACTERIAL PROTEINS; BETA-LACTAMASES; BIOFILMS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; COAGULASE; DIPEPTIDES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENOTYPE; IMIPENEM; LEVOFLOXACIN; MEMBRANE TRANSPORT PROTEINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OXACILLIN; PHENOTYPE; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; STREPTOMYCIN;

EID: 84979765527     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-016-0791-7     Document Type: Article

References (40)

1. Andersson DI, Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Micro. 2014;12(7):465-78.
2. DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest. 2009;119(9):2464-74.
3. Decousser J-W, Desroches M, Bourgeois-Nicolaos N, Potier J, Jehl F, Lina G, et al. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections. Int J Antimicrob Agent. 2015;46(6):622-30.
4. Tesařová M, Horká M, Moravcová D, Svojanovská L, Mlynarikova K, Růžička F. SDS-PAGE and gel IEF: Tool for differentiation of methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus. Curr Microbiol. 2015;72(3):315-20.
5. Munier A-L, de Lastours V, Barbier F, Chau F, Fantin B, Ruimy R. Comparative dynamics of the emergence of fluoroquinolone resistance in staphylococci from the nasal microbiota of patients treated with fluoroquinolones according to their environment. Int J Antimicrob Agent. 2015;46(6):653-9.
6. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis. 2003;9(11):1415-22.
7. Floyd JL, Smith KP, Kumar SH, Floyd JT, Varela MF. LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob Agent Chemother. 2010;54(12):5406-12.
8. Ahmed A, Azim A, Gurjar M, Baronia AK. Current concepts in combination antibiotic therapy for critically ill patients. Ind J Crit Care Med. 2014;18(5):310-4.
9. Vestergaard M, Paulander W, Marvig RL, Clasen J, Jochumsen N, Molin S, et al. Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa. Int J Antimicrob Agent. 2016;47(1):48-55.
10. Sandegren L. Selection of antibiotic resistance at very low antibiotic concentrations. Upsala J Med Sci. 2014;119(2):103-7.
11. CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard M07-A8. 2009.
12. Hamilton-Miller JMT, Shah S. Activity of glycylcyclines CL 329998 and CL 331002 against minocycline-resistant and other strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1996;37(6):1171-5.
13. CLSI. Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. Fifteenth informational supplement M100-S24 Clinical and Laboratory Standards Institute, Wayne, PA, USA. 2014.
14. Matsumoto Y, Hayama K, Sakakihara S, Nishino K, Noji H, Iino R, et al. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS ONE. 2011;6(4):e18547.
15. Sharma S, Ramnani P, Virdi JS. Detection and assay of β-lactamases in clinical and non-clinical strains of Yersinia enterocolitica biovar 1A. J Antimicrob Chemother. 2004;54(2):401-5.
16. Costa SS, Falcão C, Viveiros M, Machado D, Martins M, Melo-Cristino J, et al. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus. BMC Microbiol. 2011;11(1):1-12.
17. Martins M, Viveiros M, Couto I, Costa SS, Pacheco T, Fanning S, et al. Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method. In Vivo. 2011;25(2):171-8.
18. CT Method. Method. 2001;25(4):402-8.
19. Shahkarami F, Rashki A, Rashki GZ. Microbial susceptibility and plasmid profiles of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Jundishapur. J Microbiol. 2014;7(7):e16984.
20. Jung J-S, Shin W-S, Kim S-K, Park Y-S. Different responses of MSSA and MRSA to oxacillin of their respective MICs. J Bacteriol Virol. 2009;39:287-94.
21. Stapleton PD, Taylor PW. Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci Prog. 2002;85(Pt 1):57-72.
22. Rybak MJ, McGrath BJ. Combination antimicrobial therapy for bacterial infections. Drugs. 2012;52(3):390-405.
23. Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol. 1984;158(2):513-6.
24. Pages J-M, Lavigne J-P, Leflon-Guibout V, Marcon E, Bert F, Noussair L, et al. Efflux pump, the masked side of ß-lactam resistance in Klebsiella pneumoniae clinical isolates. PLoS ONE. 2009;4(3):e4817.
25. Pagès J-M, Masi M, Barbe J. Inhibitors of efflux pumps in Gram-negative bacteria. Trend Mol Med. 2005;11(8):382-9.
26. Yasufuku T, Shigemura K, Shirakawa T, Matsumoto M, Nakano Y, Tanaka K, et al. Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli strains clinically isolated from urinary tract infection patients. J Clin Microbiol. 2011;49(1):189-94.
27. Costa SS, Viveiros M, Amaral L, Couto I. Multidrug efflux pumps in Staphylococcus aureus: an update. Open Microbiol J. 2013;7:59-71.
28. Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. J Antimicrob Chemother. 2007;59(5):886-92.
29. Langsrud S, Sundheim G, Holck AL. Cross-resistance to antibiotics of Escherichia coli adapted to benzalkonium chloride or exposed to stress-inducers. J Appl Microbiol. 2004;96(1):201-8.
30. Kafil HS, Mobarez AM, Moghadam MF, Zs H, Yousefi M. Gentamicin induces efaA expression and biofilm formation in Enterococcus faecalis. Microb Pathog. 2016;92:30-5.
31. Fey PD, Olson ME. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol. 2010;5(6):917-33.
32. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agent. 2010;35(4):322-32.
33. Ding Y, Onodera Y, Lee JC, Hooper DC. NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. J Bacteriol. 2008;190(21):7123-9.
34. He X, Ahn J. Differential gene expression in planktonic and biofilm cells of multiple antibiotic-resistant Salmonella Typhimurium and Staphylococcus aureus. FEMS Microbiol Lett. 2011;325(2):180-8.
35. Truong-Bolduc QC, Strahilevitz J, Hooper DC. NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus. Antimicrob Agent Chemother. 2006;50(3):1104-7.
36. Ho C-M, Li C-Y, Ho M-W, Lin C-Y, Liu S-H, Lu J-J. High rate of qacA- and qacB-positive methicillin-resistant Staphylococcus aureus isolates from chlorhexidine-impregnated catheter-related bloodstream infections. Antimicrob Agent Chemother. 2012;56(11):5693-7.
37. Derzelle S, Dilasser F, Duquenne M, Deperrois V. Differential temporal expression of the staphylococcal enterotoxins genes during cell growth. Food Microbiol. 2009;26(8):896-904.
38. Schumacher MA, Miller MC, Grkovic S, Brown MH, Skurray RA, Brennan RG. Structural mechanisms of QacR induction and multidrug recognition. Science. 2001;294(5549):2158-63.
39. Andersen JL, He G-X, Kakarla P, Kc R, Kumar S, Lakra WS, et al. Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Pub Health. 2015;12(2):1487-547.
40. Levy SB. Active efflux mechanisms for antimicrobial resistance. Antimicrob Agent Chemother. 1992;36(4):695-703.